中文产业新闻精选评分47Chinese source
Nat Med | 从注射到口服：肖新华/叶子团队完成小分子GLP-1受体激动剂safiglipron治疗早期2型糖尿病的Ⅲ期研究
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.